You blew it! You had the great idea to buy into the COVID VACCINE STOCKS as a virtual no brainer. It was a great way to hedge against the stalling of the economy caused by the lockdown. You should have followed your heart and ignored that person that told you it was too risky. The FDA's fast track designation gave a boost to BioNTech and its partnership with Pfizer.
You have to be selective (read: lucky) as the average stocks was up almost 5% but 12 of the 26 were down on the day. Little Tonix fell 15% on a new stock offering and Atara was down almost 8%. There was no complacency, as only iBio moved less than 1%.
Vaxart exploded upwards to the tune of 52%. It doesn't take too many 52% days to start having a real impact on your portfolio.
Heat Biologics and BiondVax had great days: up over 20%, while some of the stalwarts like Moderna, BioNTech, Novavax, Inovio and Altimmune also had amazing days: up 10% and more.
No comments:
Post a Comment